The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000162.5(GCK):c.524G>T (p.Gly175Val)

CA367401683

1746353 (ClinVar)

Gene: GCK
Condition: monogenic diabetes
Inheritance Mode: Semidominant inheritance
UUID: 49cf4b5c-fb03-4ade-8315-3fb8aa33a104
Approved on: 2024-02-23
Published on: 2024-02-23

HGVS expressions

NM_000162.5:c.524G>T
NM_000162.5(GCK):c.524G>T (p.Gly175Val)
NC_000007.14:g.44150024C>A
CM000669.2:g.44150024C>A
NC_000007.13:g.44189623C>A
CM000669.1:g.44189623C>A
NC_000007.12:g.44156148C>A
NG_008847.1:g.44400G>T
NG_008847.2:g.53147G>T
ENST00000395796.8:c.*522G>T
ENST00000616242.5:c.524G>T
ENST00000682635.1:n.1010G>T
ENST00000345378.7:c.527G>T
ENST00000403799.8:c.524G>T
ENST00000671824.1:c.524G>T
ENST00000673284.1:c.524G>T
ENST00000345378.6:c.527G>T
ENST00000395796.7:c.521G>T
ENST00000403799.7:c.524G>T
ENST00000437084.1:c.473G>T
ENST00000616242.4:c.521G>T
NM_000162.3:c.524G>T
NM_033507.1:c.527G>T
NM_033508.1:c.521G>T
NM_000162.4:c.524G>T
NM_001354800.1:c.524G>T
NM_033507.2:c.527G>T
NM_033508.2:c.521G>T
NM_033507.3:c.527G>T
NM_033508.3:c.521G>T

Uncertain Significance

Met criteria codes 4
PM5_Supporting PM2_Supporting PP3 PP2
Not Met criteria codes 2
PP4 PP1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Monogenic Diabetes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GCK Version 1.3.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.524G>T variant in the glucokinase gene, GCK, causes an amino acid change of glycine to valine at codon 175 (p.(Gly175Val)) of NM_000162.5. GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2). This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.98, which is greater than the MDEP VCEP threshold of 0.70 (PP3). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). Another missense variant, c.523G>A p.Gly175Arg, has been classified as pathogenic by the ClinGen MDEP but has a greater Grantham distance than p.Gly175Val (PM5_Supporting). This variant segregated with diabetes with two informative meioses in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (PMID: 27236918, PMID: 11315851​). This variant was identified in an individual with a phenotype suggestive of GCK-hyperglycemia; however, PP4 is unable to be evaluated due to insufficient clinical information (PMID:28012402, 11315851, internal lab contributors). In summary, c.524G>T meets the criteria to be classified as uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3.0, approved 8/11/2023): PM2_Supporting, PP2, PP3, PM5_Supporting.
Met criteria codes
PM5_Supporting
Another missense variant, c.523G>A p.Gly175Arg, has been classified as pathogenic by the ClinGen MDEP but has a greater Grantham distance than p.Gly175Val (PM5_Supporting).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
PP3
This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.98, which is greater than the MDEP VCEP threshold of 0.70 (PP3).
PP2
GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2).
Not Met criteria codes
PP4
This variant was identified in an individual with a phenotype suggestive of GCK-hyperglycemia; however, PP4 is unable to be evaluated due to insufficient clinical information (PMID:28012402, 11315851, internal lab contributors).
PP1
This variant segregated with diabetes with two informative meioses in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (PMID: 27236918, PMID: 11315851​).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.